Francisco, Angeli .
HRN: 23-03-78 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/04/2023
METRONIDAZOLE 500MG (TAB)
06/04/2023
06/11/2023
PO
500 Mg
Every 8 Hours
S/P Episiorrhaphy
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes